These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 31083768)

  • 1. Return of the lysergamides. Part V: Analytical and behavioural characterization of 1-butanoyl-d-lysergic acid diethylamide (1B-LSD).
    Brandt SD; Kavanagh PV; Westphal F; Stratford A; Elliott SP; Dowling G; Wallach J; Halberstadt AL
    Drug Test Anal; 2019 Aug; 11(8):1122-1133. PubMed ID: 31083768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Return of the lysergamides. Part VI: Analytical and behavioural characterization of 1-cyclopropanoyl-d-lysergic acid diethylamide (1CP-LSD).
    Brandt SD; Kavanagh PV; Westphal F; Stratford A; Odland AU; Klein AK; Dowling G; Dempster NM; Wallach J; Passie T; Halberstadt AL
    Drug Test Anal; 2020 Jun; 12(6):812-826. PubMed ID: 32180350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Return of the lysergamides. Part I: Analytical and behavioural characterization of 1-propionyl-d-lysergic acid diethylamide (1P-LSD).
    Brandt SD; Kavanagh PV; Westphal F; Stratford A; Elliott SP; Hoang K; Wallach J; Halberstadt AL
    Drug Test Anal; 2016 Sep; 8(9):891-902. PubMed ID: 26456305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological and biotransformation studies of 1-acyl-substituted derivatives of d-lysergic acid diethylamide (LSD).
    Halberstadt AL; Chatha M; Klein AK; McCorvy JD; Meyer MR; Wagmann L; Stratford A; Brandt SD
    Neuropharmacology; 2020 Aug; 172():107856. PubMed ID: 31756337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Return of the lysergamides. Part II: Analytical and behavioural characterization of N
    Brandt SD; Kavanagh PV; Westphal F; Elliott SP; Wallach J; Colestock T; Burrow TE; Chapman SJ; Stratford A; Nichols DE; Halberstadt AL
    Drug Test Anal; 2017 Jan; 9(1):38-50. PubMed ID: 27265891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Return of the lysergamides. Part VII: Analytical and behavioural characterization of 1-valeroyl-d-lysergic acid diethylamide (1V-LSD).
    Brandt SD; Kavanagh PV; Westphal F; Pulver B; Morton K; Stratford A; Dowling G; Halberstadt AL
    Drug Test Anal; 2022 Apr; 14(4):733-740. PubMed ID: 34837347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological characterization of the LSD analog N-ethyl-N-cyclopropyl lysergamide (ECPLA).
    Halberstadt AL; Klein LM; Chatha M; Valenzuela LB; Stratford A; Wallach J; Nichols DE; Brandt SD
    Psychopharmacology (Berl); 2019 Feb; 236(2):799-808. PubMed ID: 30298278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Return of the lysergamides. Part III: Analytical characterization of N
    Brandt SD; Kavanagh PV; Westphal F; Elliott SP; Wallach J; Stratford A; Nichols DE; Halberstadt AL
    Drug Test Anal; 2017 Oct; 9(10):1641-1649. PubMed ID: 28342178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analytical and behavioral characterization of N-ethyl-N-isopropyllysergamide (EIPLA), an isomer of N
    Brandt SD; Kavanagh PV; Westphal F; Pulver B; Schwelm HM; Stratford A; Auwärter V; Halberstadt AL
    Drug Test Anal; 2024 Feb; 16(2):187-198. PubMed ID: 37321559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Return of the lysergamides. Part IV: Analytical and pharmacological characterization of lysergic acid morpholide (LSM-775).
    Brandt SD; Kavanagh PV; Twamley B; Westphal F; Elliott SP; Wallach J; Stratford A; Klein LM; McCorvy JD; Nichols DE; Halberstadt AL
    Drug Test Anal; 2018 Feb; 10(2):310-322. PubMed ID: 28585392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analytical profile, in vitro metabolism and behavioral properties of the lysergamide 1P-AL-LAD.
    Brandt SD; Kavanagh PV; Westphal F; Pulver B; Schwelm HM; Whitelock K; Stratford A; Auwärter V; Halberstadt AL
    Drug Test Anal; 2022 Aug; 14(8):1503-1518. PubMed ID: 35524430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the lysergic acid diethylamide analog, 1-(thiophene-2-carbonyl)-N,N-diethyllysergamide (1T-LSD) from a blotter product.
    Tanaka R; Kawamura M; Mizutani S; Kikura-Hanajiri R
    Drug Test Anal; 2024 May; 16(5):482-488. PubMed ID: 37605503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro metabolic fate of nine LSD-based new psychoactive substances and their analytical detectability in different urinary screening procedures.
    Wagmann L; Richter LHJ; Kehl T; Wack F; Bergstrand MP; Brandt SD; Stratford A; Maurer HH; Meyer MR
    Anal Bioanal Chem; 2019 Jul; 411(19):4751-4763. PubMed ID: 30617391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the head-twitch response induced by hallucinogens in mice: detection of the behavior based on the dynamics of head movement.
    Halberstadt AL; Geyer MA
    Psychopharmacology (Berl); 2013 Jun; 227(4):727-39. PubMed ID: 23407781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of 1-Butyl-Lysergic Acid Diethylamide (1B-LSD) in Seized Blotter Paper Using an Integrated Workflow of Analytical Techniques and Chemo-Informatics.
    Tsochatzis E; Lopes JA; Reniero F; Holland M; Åberg J; Guillou C
    Molecules; 2020 Feb; 25(3):. PubMed ID: 32045999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin type 5A receptor antagonists inhibit D-lysergic acid diethylamide discriminatory cue in rats.
    Popik P; Krawczyk M; Kuziak A; Bugno R; Hogendorf A; Staroń J; Nikiforuk A
    J Psychopharmacol; 2019 Nov; 33(11):1447-1455. PubMed ID: 31452444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species.
    Halberstadt AL; Chatha M; Klein AK; Wallach J; Brandt SD
    Neuropharmacology; 2020 May; 167():107933. PubMed ID: 31917152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Identification and Analysis of LSD Derivatives in Illegal Products as Paper Sheet].
    Tanaka R; Kawamura M; Hakamatsuka T; Kikura-Hanajiri R
    Yakugaku Zasshi; 2020; 140(5):739-750. PubMed ID: 32378678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phospholipase C mediates (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-, but not lysergic acid diethylamide (LSD)-elicited head bobs in rabbit medial prefrontal cortex.
    Schindler EA; Harvey JA; Aloyo VJ
    Brain Res; 2013 Jan; 1491():98-108. PubMed ID: 23123701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Identification of LSD Derivatives, 1cP-LSD, MIPLA and 1B-LSD in Illegal Products as Paper Sheet].
    Tanaka R; Kawamura M; Hakamatsuka T; Kikura-Hanajiri R
    Yakugaku Zasshi; 2020; 140(11):1405-1413. PubMed ID: 33132277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.